Hutch News

BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave Fellow

BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave Fellow

In memory of runner Gabe Grunewald, research at Fred Hutch will inform new treatments for rare and aggressive cancers
Hutch NewsOctober 17, 2023
When more is better: bevacizumab treatment for patients with ovarian cancer

When more is better: bevacizumab treatment for patients with ovarian cancer

From the Liao Group, Breast and Ovary Cancers Research Program, Cancer Consortium
Science SpotlightMay 24, 2023
Fred Hutch study highlights racial disparities in ovarian cancer risk for women

Fred Hutch study highlights racial disparities in ovarian cancer risk for women

Researchers examined risks for Black and white women with endometriosis and fibroids to understand how common medical interventions for those conditions modified the outcomes
News ReleasesMay 04, 2023
Examining factors that may impact ovarian cancer survival disparities

Examining factors that may impact ovarian cancer survival disparities

From the Harris Group, Public Health Sciences Division
Science SpotlightJune 20, 2022
Genital powder use and epithelial ovarian cancer

Genital powder use and epithelial ovarian cancer

From the Harris Group, Division of Public Health Sciences
Science SpotlightAugust 16, 2021
Scientists show thin metal mesh loaded with T cells shrinks solid tumors

Scientists show thin metal mesh loaded with T cells shrinks solid tumors

Within weeks, CAR T cells targeting ovarian cancer cleared tumors in 70% of treated mice, shows study in Nature Biomedical Engineering. (Note: Images available for media use.)
News ReleasesDecember 09, 2019
Jenny Hansen: Two-time survivor, first-time Obliterider

Jenny Hansen: Two-time survivor, first-time Obliterider

‘I am so thankful there are people out there who aren’t afraid of cancer, who pursue it’
Hutch NewsJuly 17, 2019